News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
RA CAPITAL MANAGEMENT, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Bought 1,777,778 shares
@ $9, valued at
$16M
|
|
| 08/09/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 45,000 options to buy
@ $4.58, valued at
$206.1k
|
|
| 08/09/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Former 10% owners and Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Unknown transaction of 7,070,205 shares
@ $0
Unknown transaction of 786,407 shares
@ $0
Disposed/sold 21,250 options to buy
@ $14.98, valued at
$318.3k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 935,850 shares
@ $5, valued at
$4.7M
|
|
| 06/28/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/16/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/12/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Former 10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 5,914,252 shares
@ $0
Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 06/09/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 22,500 options to buy
@ $4.86, valued at
$109.4k
|
|
| 06/08/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $16.3, valued at
$203.8k
|
|
| 06/08/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/02/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 06/02/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Former 10% owner) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Granted 1,152,460 shares
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Bought 1,923,076 shares
@ $13, valued at
$25M
|
|
| 01/10/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Bought 1,853,000 shares
@ $2.21, valued at
$4.1M
|
|
| 01/06/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Bought 122,334 shares
@ $7.0276, valued at
$859.7k
Bought 58,369 shares
@ $7.7968, valued at
$455.1k
|
|
| 01/05/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Bought 629,297 shares
@ $3.9982, valued at
$2.5M
|
|
| 12/29/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Bought 4,089 shares
@ $5.9941, valued at
$24.5k
|
|
| 12/21/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Bought 98,787 shares
@ $5.8997, valued at
$582.8k
|
|
| 12/16/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Bought 824,600 shares
@ $5.4591, valued at
$4.5M
Bought 237,029 shares
@ $5.495, valued at
$1.3M
Bought 1,341,420 shares
@ $5.4195, valued at
$7.3M
|
|
| 12/15/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.47, valued at
$62.4k
|
|
| 12/12/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Bought 10,600 shares
@ $3.75, valued at
$39.8k
Bought 19,299 shares
@ $3.93, valued at
$75.8k
|
|
| 12/09/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 11,627,907 shares
@ $4.3, valued at
$50M
|
|
| 12/05/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 2,163,120 shares
@ $7.05, valued at
$15.2M
Granted 300,412 shares
@ $0
Granted 109,661 shares
@ $0 |
|
| 11/21/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Converted 994,706 shares
@ $0
Bought 3,389,500 shares
@ $12.5, valued at
$42.4M
Converted 426,302 shares
@ $0
Converted 2,452,947 preferred shares
@ $0
Converted 1,051,263 preferred shares
@ $0 |
|
| 11/16/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Granted 35,235 options to buy
@ $12.5, valued at
$440.4k
|
|
| 11/10/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 2,106,774 shares
@ $0
Granted 902,904 shares
@ $0 |
|
| 10/24/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Bought 11,342 shares
@ $3.95, valued at
$44.8k
Bought 48,100 shares
@ $3.92, valued at
$188.6k
Bought 26,460 shares
@ $3.91, valued at
$103.5k
|
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|